India’s success story in pharma is marredby excessive dependence on imported API Budget 2025 offers a critical opportunity to address these challenges and propel the sector forward. Incentives for R&D, such as higher tax deductions or rebates, could stimulate innovation, while a National Pharma & Biotech Innovation Fund could support startups and foster academic-industry collaboration…


